Clinical Trials Directory

Trials / Completed

CompletedNCT03881566

Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients

Study of Usefulness of Presepsin as Early Detective Marker of Sepsis in Immunodeficiency ICU Patients

Status
Completed
Phase
Study type
Observational
Enrollment
119 (actual)
Sponsor
Jongmin Lee · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This is an observational study to evaluate the diagnostic and prognostic value of presepsin in the critically-ill immunocompromise patients.

Conditions

Timeline

Start date
2019-03-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2019-03-19
Last updated
2021-04-29

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03881566. Inclusion in this directory is not an endorsement.

Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients (NCT03881566) · Clinical Trials Directory